Skip to main content
. Author manuscript; available in PMC: 2010 Jul 1.
Published in final edited form as: Schizophr Res. 2009 May 2;112(1-3):65–71. doi: 10.1016/j.schres.2009.04.002

Figure 1.

Figure 1

NCAM1 expression in the cortex of schizophrenia subjects. (A) Analysis of cortical NCAM1 mRNA expression in subjects who had been diagnosed with short duration of illness (DOI) schizophrenia showed a significant increase of NCAM1 mRNA levels in BA46 (P=0.013) associated with schizophrenia. No change in NCAM1 mRNA expression was observed in BA10 (P=0.575) or BA17 (P=0.772) of subjects with short duration of illness schizophrenia compared to controls. (B) Subsequent analysis of NCAM1 mRNA expression in BA46 from a separate cohort of long DOI schizophrenia subjects showed no change in NCAM1 expression compared to control subjects (P=0.602). NCAM1 expression data is expressed relative to the expression of PPIA, SNCA and GAPDH. *= P<0.05.